Advertisement
Thursday, November 19, 2026NewslettersAdvertiseWatch FL1
GET LOCALGo ad-freeHigh school sportsLocal eventsObituaries
News

Two promising vaccines enter final stage testing as fall approaches in the U.S.

Two promising vaccines enter final stage testing as fall approaches in the U.S.

The biggest test of an experimental COVID-19 vaccine began on Monday with the first round of nearly 30,000 Americans getting a shot.

The vaccine was developed by the National Institutes of Health and Moderna Inc.

Guitar Lessons for Christmas

“I’m excited to be part of something like this. This is huge,” said Melissa Harting, a 36-year-old nurse who received an injection in Binghamton.

Another company, Pfizer Inc., is also working on a vaccine, which will test around 30,000 people.

“We’ve been sitting on the sidelines passively attempting to wear our masks and social distance and not go out when it’s not necessary. This is the first step of becoming active against this,” said Dr. Frank Eder of Meridian Clinical Research, the company that runs the Binghamton trial site. “There’s really no other way to get past this.”

Categories: NewsPoliticsHealth

Want to go ad-free?

Become an FL1 member and say goodbye to ads! Plus, you’ll be supporting a company rooted in the Finger Lakes for nearly 30 years.

$4.99 / month

Get ad-free access

Renews monthly. Cancel anytime through your account. Already contributing via Google? Sign in with your Google account and unlock ad-free access. Embedded YouTube videos and other third-party media players may still contain ads.

Start your day with FingerLakes1

Get the stories that matter from across the Finger Lakes, delivered to your inbox.

Your email will be added to our newsletter mailing list, hosted on Substack. Privacy policy